A detailed history of Opinicus Capital, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Opinicus Capital, Inc. holds 17,334 shares of BMY stock, worth $993,758. This represents 0.72% of its overall portfolio holdings.

Number of Shares
17,334
Previous 16,040 8.07%
Holding current value
$993,758
Previous $666 Million 34.63%
% of portfolio
0.72%
Previous 0.56%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$39.66 - $51.75 $51,320 - $66,964
1,294 Added 8.07%
17,334 $897 Million
Q2 2024

Jul 22, 2024

BUY
$40.25 - $52.99 $98,250 - $129,348
2,441 Added 17.95%
16,040 $666 Million
Q1 2024

Apr 16, 2024

BUY
$47.98 - $54.4 $255,205 - $289,353
5,319 Added 64.24%
13,599 $737 Million
Q4 2023

Feb 05, 2024

BUY
$48.48 - $57.85 $401,414 - $478,998
8,280 New
8,280 $425 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Opinicus Capital, Inc. Portfolio

Follow Opinicus Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opinicus Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opinicus Capital, Inc. with notifications on news.